Several recent studies pointed to the relevance of the immune infiltrate in HNSCC, showing the prognostic role of TIL specific markers, including CD56 and CD57 (20, 61, 62), CD3, CD4 and CD8 (63–68). The gene discussed is CD4; the disease is head and neck squamous cell carcinoma.